Watch More Highlights
Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, discusses key information for advanced practitioners on the impact of TP53 mutations on prognosis in myelodysplastic syndrome, the implications of serial TP53 analyses, and novel therapeutic strategies for treating patients with TP53-mutant disease.